CBT:NYE-Cabot Corporation (USD)

COMMON STOCK | Specialty Chemicals | NYE

Last Closing Price

USD 70.28

Change

-2.46 (-3.38)%

Market Cap

USD 4.06B

Volume

0.55M

Avg Analyst Target

USD 79.50 (+13.12%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


CBT Stock Forecast & Price:
Based on the Cabot Corporation stock forecasts from 2 analysts, the average analyst target price for Cabot Corporation is USD 79.50 over the next 12 months. Cabot Corporation’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Cabot Corporation is Slightly Bullish , which is based on 6 positive signals and 5 negative signals. At the last closing, Cabot Corporation’s stock price was USD 70.28. Cabot Corporation’s stock price has changed by -3.62% over the past week, +6.61% over the past month and +30.83% over the last year.

About Cabot Corporation (CBT:NYE)

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agen ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-09 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LIN Linde PLC

-0.31 (-0.10%)

USD150.49B 43.76 17.02
SHW Sherwin-Williams Co

-8.13 (-3.38%)

USD62.33B 36.11 24.44
APD Air Products and Chemicals Inc

-3.01 (-1.15%)

USD58.25B 26.88 14.30
ECL Ecolab Inc

-1.67 (-1.01%)

USD47.56B 43.47 35.51
IFF International Flavors & Fragra..

-7.53 (-5.90%)

USD32.30B 55.83 19.96
PPG PPG Industries Inc

-1.10 (-0.86%)

USD30.15B 28.57 17.75
DD Dupont De Nemours Inc

-0.69 (-1.16%)

USD29.49B 24.23 11.09
ALB Albemarle Corp

-0.18 (-0.07%)

USD28.68B 113.35 57.35
LYB LyondellBasell Industries NV

+1.26 (+1.47%)

USD28.05B 5.23 4.70
SQM Sociedad Quimica y Minera de C..

+1.37 (+1.43%)

USD27.70B 21.17 13.27

ETFs Containing CBT

Symbol Name Weight Mer Price(Change) Market Cap
DES WisdomTree U.S. SmallCap .. 0.00 % 0.38 %

-0.16 (-0.53%)

USD1.72B
FHM:CA First Trust NYSE Arca Bio.. 0.00 % 0.80 %

N/A

USD1.40M

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.05% 93% A 95% A
Dividend Return 1.32% 77% C+ 42% F
Total Return 26.37% 93% A 95% A
Trailing 12 Months  
Capital Gain 29.96% 93% A 94% A
Dividend Return 2.70% 81% B- 49% F
Total Return 32.66% 95% A 94% A
Trailing 5 Years  
Capital Gain 36.63% 76% C 68% D+
Dividend Return 13.37% 71% C- 52% F
Total Return 49.99% 82% B- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 5.57% 42% F 57% F
Dividend Return 2.93% 81% B- 64% D
Total Return 8.50% 44% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 34.52% 53% F 31% F
Risk Adjusted Return 24.61% 51% F 40% F
Market Capitalization 4.06B 51% F 72% C-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 31.56 29% F 19% F
Price/Book Ratio 4.52 18% F 17% F
Price / Cash Flow Ratio 15.80 42% F 26% F
EV/EBITDA 11.77 49% F 38% F
Management Effectiveness  
Return on Equity 16.39% 67% D+ 69% D+
Return on Invested Capital 16.91% 87% B+ 83% B
Return on Assets 8.96% 87% B+ 87% B+
Debt to Equity Ratio 75.71% 52% F 46% F
Technical Ratios  
Dividend Yield 2.06% 56% F 33% F
Short Ratio 4.49 16% F 22% F
Short Percent 3.69% 27% F 52% F
Beta 1.41 27% F 23% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.